Merck is a global pharmaceutical and chemical group with a history that began in 1668 and a future shaped by more than 40,000 employees in 67 countries. It is a global pharmaceutical industry dedicated to the patient and focused primarily on Research and Development.
Merck Serono is the largest division of Merck KGaA and deals with innovative prescription pharmaceuticals. It combines cutting-edge technology expertise in two different sectors of drug development and manufacture: the new chemical entities (NCE) and the new biological entities (NBE), the combination of which creates a unique power in the field of pharmaceutical research.
Merck Serono is one of the largest pharmaceutical companies that has made significant investments in biotechnology, acknowledging the important role it plays in the ability to discover new methods both for treatment and prevention of diseases. It invests over 20% of its total revenue or approximately 1 billion Euro annually for the discovery and development of new treatments, while the Merck Serono Biotechnology Center (MSBC) in Corsier-sur-Vevey, Switzerland, is one of the largest and most technologically advanced biotech centers in the world, which has been operating under ISO 14001:2004 certification, the international environmental standard for excellence.
Merck Chemicals offers a very wide range of specialty chemicals for technologically sophisticated applications. Our close collaboration with the globally top monitor manufacturers for the development and production of liquid crystals has enabled the Liquid Crystals Division to become a world leader in this promising market sector. Merck's clients in the food, optics, plastics, pigments, printing, cosmetics and pharmaceutical industries rely on the specialty products of the Chemicals Department for food, pharmaceuticals and cosmetics analysis, research and manufacture.
Merck A.E. Hellas is a member of the Merck Group (Darmstadt, Germany). The company operates a Pharmaceuticals division, established in the relevant market as Merck Serono, and a Chemicals division, Merck Chemicals. On 7th March 2011, all Millipore products were incorporated in Merck A.E., and so, Merck with its Merck Millipore & Performance Materials divisions will continue to be a leader in the sector of Chemistry in Greece.
Pharmaceuticals division (Merck Serono):
Treatment categories: Multiple Sclerosis, Oncology, Fertility, Growth Disorders, Cardiometabolic Disorders, Type 2 Diabetes
Merck Millipore: Products and services for Bioscience, Lab solutions, Process Solutions
Performance Materials: Liquid Crystals, Pigments & Cosmetics
41-45, Kifissias Ave. (Βuilding B)
151 23 Μaroussi, Αthens, Greece
Τel: +30 210/6165100
Fax: +30 210/6101373